{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:17:57Z","timestamp":1790047077887,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006597","name":"Florida State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2023317"],"award-info":[{"award-number":["TYH2023317"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejso.2025.109688","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:02:55Z","timestamp":1739300575000},"page":"109688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-8632","authenticated-orcid":false,"given":"Sanna","family":"Matilainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Liikanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna K.","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejso.2025.109688_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/BOT.0000000000002360","article-title":"Management of metastatic disease in long bones","volume":"36","author":"Auran","year":"2022","journal-title":"J Orthop Trauma"},{"issue":"10","key":"10.1016\/j.ejso.2025.109688_bib2","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.injury.2015.07.028","article-title":"The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon","volume":"46","author":"Bryson","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.ejso.2025.109688_bib3","first-page":"393","article-title":"Management of long bones metastatic disease: concepts that we all know but not always remember","volume":"14","author":"Gonzalez","year":"2022","journal-title":"Orthop Res Rev"},{"issue":"6","key":"10.1016\/j.ejso.2025.109688_bib4","article-title":"Metastatic bone disease: diagnosis, evaluation, and treatment","volume":"91","author":"Biermann","year":"2009","journal-title":"JBJS"},{"issue":"8","key":"10.1016\/j.ejso.2025.109688_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/00365510802126836","article-title":"Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa\u2010foeto\u2010protein (AFP), neuron\u2010specific enolase (NSE) and CA19.9 from the NORIP study","volume":"68","author":"Bjerner","year":"2008","journal-title":"Scand J Clin Lab Investig"},{"issue":"2","key":"10.1016\/j.ejso.2025.109688_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/0284186X.2019.1679881","article-title":"CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study","volume":"59","author":"Peippo","year":"2019","journal-title":"Acta Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109688_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10147-019-01452-8","article-title":"Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis","volume":"24","author":"Zang","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.109688_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jos.2017.03.014","article-title":"Risk stratification for predicting symptomatic skeletal events (SSEs) in breast cancer patients with bone metastases","volume":"22","author":"Nakata","year":"2017","journal-title":"J Orthop Sci"},{"issue":"7","key":"10.1016\/j.ejso.2025.109688_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jjco\/hyl046","article-title":"Serum tumor markers in skeletal metastasis","volume":"36","author":"Tsukushi","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109688_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3393\/ac.2019.11.13","article-title":"A review of the role of carcinoembryonic antigen in clinical practice","volume":"35","author":"Hall","year":"2019","journal-title":"Ann Coloproctol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109688_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajpath.2022.12.005","article-title":"Cancer antigen 125 expression enhances the gemcitabine\/cisplatin-resistant tumor microenvironment in bladder cancer","volume":"193","author":"Yamashita","year":"2023","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109688_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12122985","article-title":"The potential role of MUC16 (CA125) biomarker in lung cancer: a magic biomarker but with adversity","volume":"12","author":"Saad","year":"2022","journal-title":"Diagnostics"},{"issue":"14","key":"10.1016\/j.ejso.2025.109688_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144687","article-title":"Role of selected circulating tumor biomarkers in patients with skeletal metastatic pancreatic neuroendocrine neoplasms","volume":"12","author":"Rosiek","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.ejso.2025.109688_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.1986.4.10.1542","article-title":"Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer","volume":"4","author":"Hayes","year":"1986","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2025.109688_bib15","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2015.61.1459","article-title":"Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American society of clinical oncology clinical practice guideline","volume":"33","author":"van Poznak","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109688_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate antigen 19-9 \u2014 tumor marker: past, present, and future","volume":"12","author":"Lee","year":"2020","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.ejso.2025.109688_bib17","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","article-title":"Colorectal cancer tumour markers and biomarkers: recent therapeutic advances","volume":"22","author":"Lech","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109688_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European association of urology position and recommendations for 2021","volume":"80","author":"van Poppel","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109688_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.eururo.2018.10.053","article-title":"Results of prostate cancer screening in a unique cohort at 19yr of follow-up","volume":"75","author":"Osses","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109688_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bju.16211","article-title":"Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge","volume":"133","author":"Albertsen","year":"2024","journal-title":"BJU Int"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:47:57Z","timestamp":1753973277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0748798325001167"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109688","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109688"}}